Paper 2 June 2025, Question 4 10 marks
Also involves Proteins
People with the inherited blood disorder haemophilia A (HA) have a reduced ability to clot blood. One variant of HA is due to an inversion mutation in the F8 gene. This mutation causes the production of a non-functional form of the protein, factor VIII. Factor VIII is not an enzyme.
Explain how an inversion mutation can cause the production of non-functional factor VIII.
Reveal mark scheme
Currently, the most effective treatment for HA is weekly or monthly injections of factor VIII. Scientists investigated the effectiveness of a gene therapy product, Roctavian, as a treatment for HA. Roctavian contains a viral vector that has the DNA coding for factor VIII.
The scientists:
• selected 112 male volunteers with severe HA, who were at least 18 years of age
• treated each volunteer with a single injection of Roctavian into their blood
• recorded the number of bleeding episodes (internal bleeding) in these volunteers over a two-year period (set A results)
• compared these data with the number of bleeding episodes per year in the volunteers before receiving Roctavian (set B results).
Table 1 shows the scientists’ results.
A value of ±2 × SD from the mean includes over 95% of the data.
Use all the information provided to evaluate the use of Roctavian as a treatment for HA.
Reveal mark scheme
Haemophilia C is an autosomal recessive condition.
Two parents are both heterozygous for the haemophilia C allele.
Calculate the probability of these parents producing a son who has haemophilia C.
Reveal mark scheme